| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 49.2276 | 46 |
| GSM780708 | Untreated after 4 days (C2_1) | 46.9214 | 36 |
| GSM780709 | Untreated after 4 days (C3_1) | 46.4367 | 34 |
| GSM780719 | Untreated after 4 days (C1_2) | 52.9915 | 56 |
| GSM780720 | Untreated after 4 days (C2_2) | 48.4163 | 43 |
| GSM780721 | Untreated after 4 days (C3_2) | 46.766 | 36 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 45.4504 | 29 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 45.6045 | 30 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 46.4873 | 34 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 45.1933 | 28 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 52.8888 | 56 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 55.795 | 61 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 52.2938 | 55 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 35.886 | 1 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 48.7928 | 44 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 44.6317 | 25 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 50.9747 | 51 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 49.1651 | 46 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 46.7015 | 35 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 50.2455 | 49 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 49.2637 | 46 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 51.4511 | 53 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 44.8346 | 26 |